These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
449 related items for PubMed ID: 15899952
1. Safety of growth hormone treatment in pediatric patients with idiopathic short stature. Quigley CA, Gill AM, Crowe BJ, Robling K, Chipman JJ, Rose SR, Ross JL, Cassorla FG, Wolka AM, Wit JM, Rekers-Mombarg LT, Cutler GB. J Clin Endocrinol Metab; 2005 Sep; 90(9):5188-96. PubMed ID: 15899952 [Abstract] [Full Text] [Related]
2. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment. Spagnoli A, Branca F, Spadoni GL, Cianfarani S, Pasquino AM, Argirò G, Vitale S, Robins SP, Boscherini B. J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806 [Abstract] [Full Text] [Related]
3. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children. Cohen P, Germak J, Rogol AD, Weng W, Kappelgaard AM, Rosenfeld RG, American Norditropin Study Group. J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829 [Abstract] [Full Text] [Related]
4. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature. Hughes IP, Harris M, Choong CS, Ambler G, Cutfield W, Hofman P, Cowell CT, Werther G, Cotterill A, Davies PS, Australasian Paediatric Endocrine Group (APEG). Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731 [Abstract] [Full Text] [Related]
5. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency. Högler W, Briody J, Moore B, Lu PW, Cowell CT. Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578 [Abstract] [Full Text] [Related]
6. Safety of growth hormone treatment of children with idiopathic short stature: the US experience. Allen DB. Horm Res Paediatr; 2011 Nov; 76 Suppl 3():45-7. PubMed ID: 21912165 [Abstract] [Full Text] [Related]
7. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone? Colmenares A, González L, Gunczler P, Lanes R. J Pediatr Endocrinol Metab; 2012 Nov; 25(7-8):651-7. PubMed ID: 23155689 [Abstract] [Full Text] [Related]
8. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database). Darendeliler F, Ranke MB, Bakker B, Lindberg A, Cowell CT, Albertsson-Wikland K, Reiter EO, Price DA. Horm Res; 2005 Nov; 63(1):40-7. PubMed ID: 15627781 [Abstract] [Full Text] [Related]
9. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature. Kriström B, Aronson AS, Dahlgren J, Gustafsson J, Halldin M, Ivarsson SA, Nilsson NO, Svensson J, Tuvemo T, Albertsson-Wikland K. J Clin Endocrinol Metab; 2009 Feb; 94(2):483-90. PubMed ID: 19001519 [Abstract] [Full Text] [Related]
10. Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature. Kemp SF, Kuntze J, Attie KM, Maneatis T, Butler S, Frane J, Lippe B. J Clin Endocrinol Metab; 2005 Sep; 90(9):5247-53. PubMed ID: 15998780 [Abstract] [Full Text] [Related]
12. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD). Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A. Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776 [Abstract] [Full Text] [Related]
13. Reduced concentration of serum growth hormone-binding protein in children with idiopathic short stature. National Cooperative Growth Study. Carlsson LM, Attie KM, Compton PG, Vitangcol RV, Merimee TJ. J Clin Endocrinol Metab; 1994 Jun; 78(6):1325-30. PubMed ID: 8200933 [Abstract] [Full Text] [Related]
15. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center. Al Shaikh A, Daftardar H, Alghamdi AA, Jamjoom M, Awidah S, Ahmed ME, Soliman AT. Acta Biomed; 2020 Mar 19; 91(1):29-40. PubMed ID: 32191651 [Abstract] [Full Text] [Related]
16. Effects of growth hormone on cognitive function. Ross JL. Horm Res; 2005 Mar 19; 64 Suppl 3():89-94. PubMed ID: 16439850 [Abstract] [Full Text] [Related]
18. Observed and predicted total pubertal growth during treatment with growth hormone in adolescents with idiopathic growth hormone deficiency, Turner syndrome, short stature, born small for gestational age and idiopathic short stature: KIGS analysis and review. Ranke MB, Lindberg A. Horm Res Paediatr; 2011 Mar 19; 75(6):423-32. PubMed ID: 21358173 [Abstract] [Full Text] [Related]